
  
    
      
        Background_NNP
        Over_IN 32_CD million_CD elderly_JJ Americans_NNPS are_VBP enrolled_VBN in_IN the_DT
        Medicare_NNP health_NN insurance_NN program_NN ._. Since_IN 1982_CD ,_, the_DT Health_NNP
        Care_NNP Financing_NNP Administration_NNP has_VBZ offered_VBN a_DT managed_VBN care_NN
        option_NN ,_, with_IN capitated_JJ payment_NN ,_, to_TO Medicare_NNP enrollees_NNS ._.
        Currently_RB nearly_RB 15_CD %_NN of_IN Medicare_NNP enrollees_NNS are_VBP members_NNS of_IN
        managed_VBN care_NN plans_NNS nationwide_JJ ._. [_NN 1_CD ]_NN
        The_DT economic_JJ incentives_NNS of_IN capitated_JJ payment_NN have_VBP raised_VBN
        concerns_NNS that_WDT managed_VBD care_NN organizations_NNS that_WDT use_NN
        capitation_NN might_MD limit_VB provision_NN of_IN effective_JJ services_NNS as_IN a_DT
        way_NN of_IN trimming_VBG costs_NNS ._. [_NN 2_CD 3_CD 4_CD 5_CD ]_NN Public_NNP concerns_NNS about_IN
        restriction_NN of_IN service_NN in_IN managed_VBN care_NN organizations_NNS have_VBP
        led_VBN to_TO proposed_VBN legislation_NN for_IN a_DT "_'' patient_NN 's_POS bill_NN of_IN
        rights_NNS ._. "_'' [_NN 6_CD ]_NN once_RB again_RB being_VBG considered_VBN in_IN the_DT US_NNP
        Senate_NNP ._. [_NN 7_CD ]_NN It_PRP is_VBZ becoming_VBG clear_JJ ,_, however_RB ,_, that_IN "_'' managed_VBN
        care_NN "_'' is_VBZ not_RB a_DT single_JJ entity_NN ,_, and_CC that_IN a_DT wide_JJ range_NN of_IN
        economic_JJ incentives_NNS and_CC disincentives_NNS may_MD be_VB created_VBN in_IN
        various_JJ forms_NNS of_IN managed_VBN care_NN ,_, [_NN 8_CD ]_NN each_DT likely_JJ to_TO have_VB
        different_JJ kinds_NNS of_IN influence_NN on_IN clinician_NN behavior_NN ._. [_NN 9_CD 10_CD
        11_CD ]_NN The_DT proximity_NN of_IN risk_NN to_TO the_DT clinician_NN or_CC clinician_NN
        group_NN has_VBZ an_DT especially_RB strong_JJ effect_NN on_IN behavior_NN ._. [_NN 12_CD ]_NN
        Systems_NNPS maintained_VBN by_IN managed_VBN care_NN organizations_NNS to_TO assist_VB
        clinicians_NNS in_IN providing_VBG quality_NN care_NN also_RB differ_VB widely_RB ,_,
        and_CC may_MD strongly_RB influence_VB performance_NN ._.
        Although_IN reduced_VBN access_NN to_TO care_VB is_VBZ a_DT theoretical_JJ risk_NN of_IN
        capitated_JJ payment_NN ,_, relatively_RB few_JJ studies_NNS have_VBP addressed_VBN
        whether_IN this_DT concern_NN is_VBZ borne_VBN out_IN in_IN practice_NN ._. Perhaps_RB
        because_IN of_IN the_DT variation_NN in_IN managed_VBN care_NN arrangements_NNS ,_, the_DT
        results_NNS of_IN studies_NNS have_VBP been_VBN mixed_JJ ._. [_NN 13_CD ]_NN If_IN managed_VBN care_NN
        presents_VBZ barriers_NNS to_TO access_VB to_TO effective_JJ care_NN ,_, the_DT elderly_JJ
        would_MD be_VB especially_RB vulnerable_JJ because_IN they_PRP have_VBP a_DT higher_JJR
        burden_NN of_IN illness_NN than_IN the_DT rest_NN of_IN the_DT population_NN ._. We_PRP
        therefore_RB created_VBD indicators_NNS in_IN several_JJ domains_NNS for_IN which_WDT
        it_PRP was_VBD known_VBN that_DT care_NN improved_VBD outcomes_NNS ._. We_PRP then_RB used_VBD
        these_DT indicators_NNS to_TO compare_VB health_NN care_NN received_VBN by_IN elderly_JJ
        Medicare_NNP beneficiaries_NNS in_IN three_CD kinds_NNS of_IN payment_NN
        arrangements_NNS :_: a_DT capitated_JJ ,_, staff-model_JJ health_NN maintenance_NN
        organization_NN (_( HMO_NNP )_) and_CC a_DT partially_RB capitated_JJ group-model_JJ
        HMO_NNP ,_, both_DT parts_NNS of_IN the_DT same_JJ managed_VBN care_NN organization_NN ,_, and_CC
        in_IN fee-for-service_JJ (_( FFS_NNP )_) care_NN in_IN the_DT same_JJ geographic_JJ
        area_NN ._.
      
      
        Methods_NNP
        
          Study_NN site_NN
          
            Staff_NN model_NN HMO_NNP
            The_DT Staff_NNP Model_NNP division_NN of_IN HPHC_NNP provided_VBD primary_JJ
            care-based_JJ ,_, multi-specialty_JJ care_NN ._. The_DT organization_NN has_VBZ
            cared_VBN for_IN aged_VBN Medicare_NNP patients_NNS in_IN risk_NN and_CC other_JJ
            commercial_JJ plans_NNS since_IN the_DT mid-_NN 1980_CD 's_POS ._. All_DT primary_JJ care_NN
            providers_NNS were_VBD salaried_JJ and_CC there_EX were_VBD no_DT specific_JJ
            economic_JJ incentives_NNS (_( i_NNP ._. e_SYM ._. no_DT bonuses_NNS of_IN any_DT kind_NN )_) for_IN
            individual_JJ providers_NNS during_IN the_DT study_NN period_NN ._.
            Information_NNP on_IN all_DT ambulatory_JJ services_NNS ,_, including_VBG
            visits_NNS ,_, diagnoses_NNS ,_, procedures_NNS and_CC tests_NNS ,_, was_VBD maintained_VBN
            electronically_RB for_IN all_DT members_NNS as_IN part_NN of_IN an_DT Automated_NNP
            Medical_NNP Record_NNP System_NNP (_( AMRS_NNP ._. )_) [_NN 14_CD ]_NN These_DT data_NNS have_VBP
            been_VBN used_VBN in_IN previous_JJ studies_NNS ._. [_NN 15_CD 16_CD 17_CD ]_NN The_DT Staff_NNP
            Model_NNP HMO_NNP contracted_VBD with_IN area_NN hospitals_NNS for_IN inpatient_NN
            services_NNS ._. For_IN hospitalization_NN and_CC other_JJ outside_JJ
            utilization_NN ,_, the_DT HMO_NNP maintains_VBZ claims_NNS data_NNS using_VBG ICD-_NNP 9_CD
            codes_NNS ;_: this_DT data_NNS structure_NN contains_VBZ up_IN to_TO six_CD diagnoses_NNS
            and_CC up_IN to_TO 3_CD surgical_JJ procedures_NNS per_IN claim_NN ._.
          
          
            Group_NNP model_NN HMO_NNP
            The_DT Group_NNP Model_NNP division_NN of_IN HPHC_NNP included_VBD 16_CD medical_JJ
            groups_NNS in_IN 1993_CD that_WDT contracted_VBD with_IN the_DT HMO_NNP on_IN a_DT
            non-exclusive_JJ basis_NN ,_, i_NNP ._. e_SYM ._. they_PRP were_VBD exclusive_JJ with_IN
            regard_NN to_TO other_JJ managed_VBN care_NN plans_NNS ,_, but_CC not_RB with_IN
            respect_NN to_TO indemnity_NN insurance_NN ._. Most_JJS were_VBD primary_JJ care_NN
            groups_NNS but_CC a_DT small_JJ number_NN were_VBD multispecialty_NN groups_NNS ._.
            Payment_NN of_IN groups_NNS was_VBD based_VBN on_IN various_JJ forms_NNS of_IN
            capitation_NN ;_: the_DT most_RBS common_JJ arrangement_NN was_VBD for_IN groups_NNS
            to_TO be_VB capitated_JJ for_IN both_DT primary_NN and_CC specialty_NN
            outpatient_NN care_NN ,_, and_CC for_IN hospitalization_NN risk_NN to_TO be_VB
            shared_VBN in_IN a_DT wider_JJR pool_NN ._. Capitation_NNP rates_NNS and_CC details_NNS
            such_JJ as_IN loss-limit_JJ provisions_NNS varied_VBD from_IN group_NN to_TO
            group_VB ._. Almost_RB all_DT groups_NNS comprised_VBN between_IN 5_CD and_CC 10_CD
            physicians_NNS ._.
            Data_NNS from_IN the_DT Group_NNP Model_NNP were_VBD obtained_VBN from_IN claims_NNS
            that_WDT were_VBD submitted_VBN to_TO the_DT HMO_NNP to_TO document_VB care_NN for_IN
            calculations_NNS pertinent_JJ to_TO loss-limit_JJ provisions_NNS ,_, even_RB
            though_IN payments_NNS were_VBD not_RB based_VBN on_IN the_DT claims_NNS
            themselves_PRP ._. Data_NNP files_NNS contained_VBD information_NN on_IN
            services_NNS provided_VBN in_IN the_DT offices_NNS of_IN the_DT primary_JJ care_NN
            clinicians_NNS ,_, on_IN outpatient_NN services_NNS not_RB provided_VBN by_IN the_DT
            primary_JJ care_NN provider_NN ,_, (_( i_NNP ._. e_SYM ._. referrals_NNS )_) ,_, and_CC on_IN
            hospitalizations_NNS ._. Diagnoses_NNP and_CC procedures_NNS were_VBD coded_VBN
            using_VBG ICD-_NNP 9_CD and_CC CPT-_NNP 4_CD codes_NNS ._.
            Demographic_NNP and_CC insurance_NN coverage_NN information_NN on_IN
            members_NNS in_IN the_DT study_NN were_VBD obtained_VBN from_IN HMO_NNP enrollment_NN
            files_NNS ._.
          
          
            Fee-for-service_NNP
            Medicare_NNP beneficiaries_NNS were_VBD included_VBN in_IN this_DT study_NN
            if_IN they_PRP were_VBD :_: age_NN 65_CD and_CC older_JJR as_IN of_IN January_NNP 1_CD ,_, 1994_CD ;_:
            had_VBD both_DT Part_NN A_DT and_CC B_NNP coverage_NN for_IN at_IN least_JJS 12_CD
            consecutive_JJ months_NNS during_IN 1994_CD and_CC 1995_CD ;_: were_VBD not_RB
            enrolled_VBN in_IN an_DT HMO_NNP during_IN these_DT 12_CD consecutive_JJ months_NNS ;_:
            and_CC resided_VBN within_IN the_DT HMO_NNP catchment_NN area_NN (_( see_VB
            below_IN )_) ._.
            We_PRP matched_VBD Medicare_NNP members_NNS enrolled_VBD in_IN the_DT HMO_NNP with_IN
            those_DT in_IN fee-for-service_JJ by_IN area_NN of_IN residence_NN ._. First_LS ,_,
            we_PRP constructed_VBN a_DT list_NN of_IN the_DT zip_NN codes_NNS in_IN which_WDT
            eligible_JJ HMO_NNP members_NNS resided_VBN during_IN the_DT study_NN period_NN ._.
            We_PRP constructed_VBN a_DT list_NN of_IN Medicare_NNP fee-for-service_JJ
            beneficiaries_NNS residing_VBG in_IN the_DT comparison_NN area_NN
            consisting_VBG of_IN all_DT contiguous_JJ zip_NN codes_NNS in_IN which_WDT at_IN
            least_JJS one_CD HMO_NNP Medicare_NNP beneficiary_NN resided_VBN ._. The_DT
            resulting_VBG sample_NN included_VBD 339_CD ,_, 627_CD people_NNS ._.
            Data_NNS for_IN the_DT fee-for-service_JJ sample_NN were_VBD obtained_VBN
            from_IN an_DT enrollment_NN file_NN for_IN demographic_JJ information_NN ,_,
            the_DT MedPAR_NNP (_( Medicare_NNP Provider_NNP Analysis_NNP and_CC Review_NNP )_) file_VB
            for_IN hospitalization_NN claim_NN data_NNS ,_, Part_NNP B_NNP
            physician_NN /_NN supplier_NN claims_NNS file_VBP ,_, and_CC Hospital_NNP Outpatient_NNP
            Department_NNP claims_VBZ file_VBP ._.
          
        
        
          Performance_NN indicators_NNS
          We_PRP developed_VBD performance_NN measures_NNS that_WDT met_VBD several_JJ or_CC
          all_DT of_IN the_DT following_JJ criteria_NNS :_: the_DT disease_NN or_CC condition_NN
          was_VBD relatively_RB common_JJ and_CC potentially_RB severe_JJ ;_: a_DT clinical_JJ
          service_NN that_WDT could_MD affect_VB the_DT health_NN outcome_NN of_IN the_DT
          patient_NN was_VBD identifiable_JJ ;_: the_DT performance_NN of_IN the_DT
          indicated_VBN service_NN depended_VBD in_IN part_NN on_IN the_DT role_NN of_IN a_DT
          physician_NN or_CC health_NN system_NN and_CC not_RB only_RB on_IN the_DT patient_NN ;_:
          service_NN performance_NN was_VBD potentially_RB subject_JJ to_TO financial_JJ
          incentives_NNS ;_: it_PRP was_VBD possible_JJ from_IN other_JJ research_NN to_TO assume_VB
          that_IN the_DT indicated_VBN service_NN would_MD on_IN average_JJ improve_VB
          outcome_NN ;_: and_CC data_NNS to_TO construct_VB the_DT indicator_NN were_VBD
          currently_RB or_CC potentially_RB available_JJ ._.
          Our_PRP$ indicators_NNS assessed_VBD access_NN to_TO health_NN care_NN in_IN three_CD
          domains_NNS (_( Table_NNP 1_LS )_) :_: 1_LS )_) 
          preventive_JJ care_NN ,_, including_VBG services_NNS
          that_WDT provide_VBP future_JJ ,_, not_RB current_JJ ,_, benefit_NN ;_: 2_LS )_) 
          diagnosis-specific_JJ care_NN ,_, examining_VBG
          treatment_NN for_IN acute_JJ conditions_NNS or_CC episodes_NNS of_IN disease_NN ;_:
          and_CC 3_LS )_) 
          chronic_JJ disease_NN care_NN ,_, including_VBG
          secondary_JJ prevention_NN ._. The_DT selection_NN of_IN preventive_JJ care_NN
          indicators_NNS was_VBD guided_VBN by_IN the_DT generic_JJ applicability_NN of_IN
          these_DT maneuvers_NNS in_IN this_DT age_NN group_NN ,_, making_VBG it_PRP unnecessary_JJ
          to_TO define_VB a_DT special_JJ population_NN for_IN whom_WP the_DT procedure_NN
          would_MD be_VB indicated_VBN ._. The_DT indicators_NNS of_IN timely_JJ follow-up_JJ
          after_IN hospitalization_NN (_( diagnosis-specific_JJ care_NN )_) were_VBD
          selected_VBN based_VBN on_IN the_DT seriousness_NN of_IN the_DT medical_JJ
          conditions_NNS ;_: [_NN 18_CD ]_NN the_DT time_NN interval_NN between_IN hospital_NN
          discharge_NN and_CC outpatient_NN visit_NN were_VBD determined_VBN by_IN a_DT panel_NN
          of_IN physicians_NNS ._.
          A_DT panel_NN of_IN national_JJ experts_NNS in_IN access_NN to_TO quality_NN
          health_NN care_NN ,_, convened_VBN by_IN the_DT Health_NNP Care_NNP Financing_NNP
          Administration_NNP in_IN March_NNP of_IN 1996_CD ,_, suggested_VBD additions_NNS to_TO
          our_PRP$ original_JJ indicator_NN set_VBN ._. We_PRP then_RB selected_VBD those_DT that_IN
          best_JJS met_VBN the_DT structured_VBN evaluation_NN criteria_NNS ,_, including_VBG at_IN
          least_JJS two_CD indicators_NNS in_IN each_DT of_IN the_DT domains_NNS ._. Table_NNP 1_CD shows_VBZ
          the_DT indicators_NNS organized_VBN by_IN domains_NNS ._. More_RBR complete_JJ
          definitions_NNS of_IN inclusion_NN criteria_NNS and_CC coding_VBG ,_, including_VBG
          specific_JJ AMRS_NNP ,_, ICD-_NNP 9_CD and_CC CPT_NNP codes_NNS used_VBN ,_, have_VBP been_VBN
          published_VBN elsewhere_RB [_NN 19_CD ]_NN and_CC are_VBP summarized_VBD in_IN
          Additional_JJ fileIndicator_NN Definitions_NNP ._.
        
        
          Statistical_NNP analyses_NNS
          We_PRP compared_VBD the_DT three_CD samples_NNS by_IN age_NN category_NN using_VBG
          the_DT chi-square_JJ test_NN ._. For_IN annual_JJ indicators_NNS ,_, we_PRP averaged_VBD
          utilization_NN rates_NNS for_IN 1994_CD and_CC 1995_CD ;_: the_DT denominators_NNS
          were_VBD individuals_NNS eligible_JJ for_IN each_DT calendar_NN year_NN ._. We_PRP
          calculated_VBN rates_NNS in_IN three_CD age_NN strata_NN :_: age_NN 65_CD -_: 74_CD ,_, 75_CD -_: 84_CD ,_,
          and_CC 85_CD years_NNS and_CC older_JJR ._. We_PRP also_RB calculated_VBD age-adjusted_JJ
          rates_NNS standardized_JJ to_TO the_DT fee-for-service_JJ sample_NN ._.
          Analyses_NNS were_VBD performed_VBN using_VBG SAS_NNP ._. [_NN 20_CD ]_NN We_PRP conducted_VBD
          two-way_JJ comparisons_NNS of_IN age-adjusted_JJ rates_NNS across_IN the_DT
          three_CD samples_NNS (_( Staff_NNP Model_NNP ,_, Group_NNP Model_NNP ,_, and_CC
          fee-for-service_JJ )_) using_VBG the_DT chi-square_JJ test_NN ._.
        
      
      
        Results_NNS
        Demographic_NNP characteristics_NNS of_IN the_DT study_NN subjects_NNS are_VBP
        shown_VBN in_IN Table_NNP 2_CD ._. The_DT FFS_NNP population_NN in_IN the_DT region_NN under_IN
        study_NN was_VBD older_JJR than_IN the_DT nationwide_JJ Medicare_NNP population_NN ,_,
        and_CC a_DT slightly_RB larger_JJR proportion_NN was_VBD female_JJ (_( 62_CD %_NN versus_CC
        60_CD %_NN ,_, p_NN <_NN 0_CD ._. 001_CD )_) ._. Those_DT enrolled_VBD in_IN the_DT HMO_NNP were_VBD younger_JJR
        than_IN both_DT the_DT geographically_RB matched_VBN ,_, fee-for-service_JJ
        sample_NN and_CC Medicare_NNP enrollees_NNS in_IN the_DT US_NNP as_IN a_DT whole_JJ (_( p_NN <_NN
        0_CD ._. 001_CD )_) ,_, and_CC they_PRP were_VBD less_RBR likely_JJ to_TO be_VB female_JJ (_( p_NN
        0_CD ._. 001_CD )_) ._.
        Age-adjusted_NNP rates_NNS of_IN breast_NN cancer_NN screening_NN with_IN
        mammography_NN were_VBD substantially_RB higher_JJR in_IN the_DT two_CD HMO_NNP
        settings_NNS than_IN under_IN fee-for-service_JJ insurance_NN ._. (_( Table_NNP 3_LS )_) ._.
        Mammography_NNP screening_NN rates_NNS in_IN the_DT Staff_NNP Model_NNP were_VBD nearly_RB
        double_VB those_DT in_IN the_DT FFS_NNP sample_NN ._. The_DT proportion_NN of_IN Medicare_NNP
        enrollees_NNS who_WP saw_VBD a_DT clinician_NN within_IN a_DT one-year_JJ period_NN
        (_( Annual_JJ visit_NN rate_NN ,_, Table_NNP 3_LS )_) was_VBD greater_JJR than_IN 85_CD %_NN in_IN all_DT
        three_CD groups_NNS ;_: however_RB ,_, this_DT rate_NN was_VBD significantly_RB higher_JJR
        in_IN the_DT Staff_NNP Model_NNP HMO_NNP (_( 94_CD %_NN )_) than_IN the_DT fee-for-service_JJ
        sample_NN (_( 88_CD %_NN )_) (_( p_NN <_NN 0_CD ._. 001_CD )_) ._.
        Proportion_NNP with_IN follow_VB up_RB by_IN either_DT a_DT primary_JJ care_NN
        physician_NN or_CC cardiologist_NN within_IN 60_CD days_NNS of_IN hospital_NN
        discharge_NN after_IN myocardial_NN infarction_NN (_( Table_NNP 4_LS )_) was_VBD similar_JJ
        in_IN the_DT two_CD managed_VBN care_NN divisions_NNS and_CC ,_, in_IN both_DT cases_NNS ,_,
        higher_JJR than_IN under_IN fee-for-service_JJ insurance_NN (_( 91_CD %_NN and_CC 93_CD %_NN in_IN
        the_DT Staff_NNP and_CC Group_NNP Model_NNP respectively_RB ,_, compared_VBN to_TO 73_CD %_NN in_IN
        FFS_NNP ;_: p_NN <_NN 0_CD ._. 001_CD )_) ._. Follow_VB up_RB within_IN 14_CD days_NNS after_IN
        hospitalization_NN for_IN depression_NN was_VBD highest_JJS in_IN the_DT Group_NNP
        Model_NNP HMO_NNP ,_, although_IN small_JJ sample_NN size_NN limited_JJ our_PRP$ ability_NN
        to_TO find_VB statistically_RB significant_JJ differences_NNS (_( p_NN >_NN
        0_CD ._. 3_LS )_) ._.
        Care_NNP of_IN chronic_JJ diseases_NNS is_VBZ summarized_VBD in_IN Table_NNP 5_CD ._.
        Screening_NNP rates_NNS for_IN diabetic_JJ retinopathy_NN were_VBD higher_JJR in_IN
        both_DT divisions_NNS of_IN the_DT managed_VBN care_NN organization_NN than_IN in_IN the_DT
        fee-for-service_JJ sample_NN ._. The_DT proportion_NN of_IN diabetics_NNS with_IN 2_CD
        or_CC more_JJR visits_NNS was_VBD 50_CD %_NN higher_JJR in_IN managed_VBN care_NN than_IN in_IN
        fee-for-service_JJ (_( 95_CD %_NN and_CC 91_CD %_NN in_IN the_DT Staff_NNP and_CC Group_NNP Model_NNP ,_,
        respectively_RB ,_, versus_CC 61_CD %_NN in_IN FFS_NNP ,_, p_NN <_NN 0_CD ._. 001_CD )_) ._.
      
      
        Discussion_NNP
        We_PRP developed_VBD a_DT set_NN of_IN indicators_NNS of_IN access_NN to_TO effective_JJ
        care_NN for_IN elderly_JJ people_NNS insured_VBN by_IN Medicare_NNP designed_VBD to_TO fit_VB
        varying_VBG clinical_JJ settings_NNS ,_, insurance_NN structures_NNS ,_, and_CC data_NNS
        systems_NNS ._. In_IN general_JJ ,_, performance_NN in_IN both_DT the_DT Staff_NNP and_CC
        Group_NNP Model_NNP divisions_NNS of_IN the_DT managed_VBN care_NN plan_NN studied_VBN was_VBD
        equivalent_JJ to_TO or_CC better_JJR than_IN that_DT in_IN the_DT fee-for-service_JJ
        sector_NN ._. Other_JJ investigators_NNS have_VBP devised_VBN administrative_JJ
        claims-based_JJ indicators_NNS ,_, [_NN 21_CD 22_CD ]_NN and_CC chart_VB review-based_JJ
        indicators_NNS for_IN hospitals_NNS ,_, [_NN 23_CD ]_NN and_CC ambulatory_JJ care_NN sites_NNS ,_,
        [_NN 24_CD ]_NN in_IN efforts_NNS to_TO compare_VB hospital_NN performance_NN or_CC health_NN
        plan_NN performance_NN ._. In_IN contrast_NN ,_, we_PRP explored_JJ the_DT feasibility_NN
        of_IN using_VBG data_NNS elements_NNS available_JJ in_IN an_DT automated_VBN outpatient_NN
        medical_JJ record_NN ,_, which_WDT are_VBP increasingly_RB prevalent_JJ ,_, in_IN
        addition_NN to_TO those_DT available_JJ in_IN claims_NNS databases_NNS ._. The_DT
        indicators_NNS we_PRP selected_VBD overlap_VB with_IN those_DT chosen_VBN to_TO be_VB
        included_VBN in_IN the_DT Health_NNP Plan_NNP Employer_NNP Data_NNP and_CC Information_NNP
        Set_NNP (_( HEDIS_NNP )_) for_IN the_DT Medicare_NNP population_NN ,_, released_VBN in_IN 1997_CD ,_,
        which_WDT also_RB evaluates_VBZ breast_NN cancer_NN screening_NN and_CC retinal_JJ
        screening_NN for_IN diabetics_NNS ._. [_NN 25_CD ]_NN
        Previous_JJ studies_NNS comparing_VBG performance_NN indicators_NNS across_IN
        insurance_NN types_NNS have_VBP found_VBN inconsistent_JJ results_NNS ._. HMO_NNP
        performance_NN on_IN preventive_JJ services_NNS is_VBZ consistently_RB higher_JJR
        than_IN in_IN FFS_NNP settings_NNS ._. [_NN 26_CD 27_CD 28_CD ]_NN On_IN the_DT other_JJ hand_NN ,_, some_DT
        studies_NNS '_POS findings_NNS have_VBP raised_VBN a_DT concern_NN that_IN vulnerable_JJ
        populations_NNS such_JJ as_IN the_DT chronically_RB ill_JJ [_NN 29_CD ]_NN and_CC the_DT
        elderly_JJ [_NN 30_CD ]_NN fare_NN less_RBR well_RB in_IN HMOs_NNP than_IN in_IN FFS_NNP care_NN ._. In_IN
        the_DT Medicare_NNP population_NN ,_, data_NNS to_TO support_VB concern_NN about_IN
        worse_JJR outcomes_NNS of_IN care_NN in_IN HMOs_NNP has_VBZ come_VBN from_IN a_DT national_JJ
        telephone_NN survey_NN about_IN persistence_NN of_IN symptoms_NNS ._. [_NN 29_CD ]_NN
        In_IN numerous_JJ other_JJ investigations_NNS ,_, however_RB ,_, care_NN for_IN the_DT
        Medicare_NNP population_NN provided_VBN by_IN HMOs_NNP has_VBZ been_VBN shown_VBN to_TO be_VB
        comparable_JJ to_TO that_DT in_IN FFS_NNP ._. No_DT differences_NNS between_IN HMO_NNP and_CC
        FFS_NNP samples_NNS were_VBD found_VBN in_IN studies_NNS of_IN care_NN for_IN colon_NN cancer_NN ,_,
        [_NN 31_CD 3_CD 2_CD ]_NN breast_NN cancer_NN ,_, [_NN 33_CD 34_CD ]_NN prostate_NN cancer_NN ,_, [_NN 35_CD ]_NN
        cardiovascular_JJ disease_NN ,_, [_NN 36_CD ]_NN rheumatoid_NN arthritis_NN ,_, [_NN 37_CD ]_NN
        congestive_JJ heart_NN failure_NN ,_, [_NN 38_CD ]_NN hypertension_NN ,_, [_NN 39_CD ]_NN acute_JJ
        myocardial_NN infarction_NN ,_, [_NN 40_CD ]_NN acute_JJ appendicitis_NNS ,_, [_NN 41_CD ]_NN
        and_CC stroke_NN ._. [_NN 42_CD ]_NN One_CD study_NN found_VBD that_IN functional_JJ status_NN
        did_VBD not_RB decline_VB faster_RBR among_IN Medicare_NNP recipients_NNS enrolled_VBD
        in_IN HMOs_NNP versus_CC those_DT in_IN FFS_NNP ._. [_NN 43_CD ]_NN Our_PRP$ findings_NNS are_VBP
        consonant_JJ with_IN these_DT previous_JJ studies_NNS :_: for_IN example_NN ,_, a_DT
        higher_JJR rate_NN of_IN mammography_NN screening_NN as_IN seen_VBN in_IN our_PRP$ managed_VBN
        care_NN population_NN could_MD explain_VB the_DT trend_NN to_TO earlier_JJR stage_NN
        breast_NN cancers_NNS seen_VBN in_IN California_NNP among_IN HMO_NNP enrollees_NNS
        compared_VBN to_TO FFS_NNP ._. [_NN 31_CD ]_NN ,_, [_NN 32_CD ]_NN While_IN most_JJS of_IN previous_JJ
        work_NN focussed_JJ on_IN specific_JJ disease_NN entities_NNS ,_, we_PRP studied_VBD the_DT
        general_JJ Medicare_NNP population_NN and_CC measured_VBN indicators_NNS
        applicable_JJ to_TO all_DT enrollees_NNS ,_, as_RB well_RB as_IN indicators_NNS focussed_JJ
        on_IN specific_JJ disease-populations_JJ ._.
        There_EX are_VBP few_JJ studies_NNS of_IN the_DT effect_NN of_IN managed_VBN care_NN
        structure_NN ,_, (_( e_SYM ._. g_SYM ._. Group_NNP vs_NNS ._. Staff_NN vs_NNS ._. IPA_NNP models_NNS )_) on_IN
        indicators_NNS of_IN quality_NN care_NN ._. [_NN 44_CD 45_CD ]_NN These_DT models_NNS differ_VBP
        both_DT in_IN the_DT extent_NN to_TO which_WDT financial_JJ risk_NN is_VBZ attached_VBN to_TO
        individual_JJ providers_NNS ,_, and_CC also_RB the_DT degree_NN to_TO which_WDT
        providers_NNS are_VBP effectively_RB formed_VBN into_IN an_DT organized_VBN system_NN
        of_IN care_NN ._. For_IN example_NN some_DT of_IN the_DT differences_NNS seen_VBN in_IN our_PRP$
        study_NN between_IN the_DT Group_NNP and_CC Staff_NNP Model_NNP were_VBD probably_RB due_JJ
        to_TO organizational_JJ processes_VBZ and_CC systems_NNS in_IN place_NN in_IN the_DT
        Staff_NNP Model_NNP ,_, such_JJ as_IN physician_NN reminder_NN systems_NNS for_IN
        preventive_JJ services_NNS leading_VBG to_TO higher_JJR rates_NNS of_IN breast_NN
        cancer_NN screening_NN ._.
        This_DT study_NN has_VBZ several_JJ strengths_NNS ._. We_PRP included_VBD a_DT large_JJ
        number_NN of_IN Medicare_NNP enrollees_NNS covered_VBN by_IN the_DT health_NN plan_NN
        studied_VBD ,_, and_CC the_DT universe_NN of_IN fee-for-service_JJ Medicare_NNP
        enrollees_NNS in_IN the_DT same_JJ geographic_JJ region_NN ._. Matching_NNP by_IN region_NN
        reduces_VBZ the_DT variation_NN that_WDT may_MD have_VB affected_VBN some_DT previous_JJ
        comparisons_NNS of_IN FFS_NNP and_CC HMO_NNP populations_NNS ,_, in_IN which_WDT national_JJ
        samples_NNS were_VBD used_VBN ._. [_NN 46_CD ]_NN This_DT method_NN also_RB automatically_RB
        accounts_VBZ for_IN any_DT "_'' spillover_NN "_'' effect_NN of_IN managed_VBN care_NN
        practices_NNS onto_IN fee-for_JJ service_NN practice_NN ,_, wherein_WRB
        cost-saving_JJ techniques_NNS are_VBP applied_VBN widely_RB by_IN providers_NNS ,_,
        even_RB to_TO those_DT with_IN fee-for-service_JJ insurance_NN ,_, in_IN a_DT market_NN
        with_IN high_JJ penetration_NN of_IN managed_VBN care_NN insurance_NN ._. [_NN 47_CD ]_NN In_IN
        contrast_NN to_TO studies_NNS that_WDT focus_VBP on_IN inpatient_NN data_NNS (_( in_IN part_NN
        because_IN of_IN their_PRP$ ready_JJ availability_NN ,_, )_) [_NN 48_CD ]_NN our_PRP$ focus_NN on_IN
        outpatient_NN care_NN is_VBZ highly_RB relevant_JJ to_TO comparisons_NNS of_IN
        managed_VBN care_NN with_IN fee-for-service_JJ care_NN [_NN 49_CD ]_NN in_IN terms_NNS of_IN
        ambulatory_JJ practices_NNS that_WDT may_MD prevent_VB hospitalizations_NNS ._. Our_PRP$
        work_NN on_IN the_DT time_NN period_NN 1994_CD -_: 95_CD follows_VBZ the_DT transformations_NNS
        in_IN managed_VBN care_NN in_IN 1991_CD -_: 1993_CD ,_, and_CC thus_RB can_MD been_VBN seen_VBN as_IN an_DT
        update_NN to_TO previous_JJ studies_NNS of_IN the_DT topic_NN ._. [_NN 13_CD ]_NN
        Our_PRP$ study_NN also_RB has_VBZ limitations_NNS ._. People_NNS enrolling_VBG in_IN
        managed_VBN care_NN organizations_NNS may_MD be_VB systematically_RB different_JJ
        from_IN those_DT choosing_VBG fee-for-service_JJ arrangements_NNS ._. [_NN 50_CD ]_NN
        For_IN example_NN ,_, patients_NNS who_WP are_VBP sicker_NN or_CC more_RBR disabled_JJ may_MD
        not_RB enroll_VB ,_, [_NN 28_CD ]_NN or_CC may_MD differentially_RB choose_VB to_TO leave_VB
        managed_VBN care_NN ._. [_NN 51_CD ]_NN Those_DT who_WP do_VBP enroll_VB could_MD be_VB more_RBR
        aggressive_JJ in_IN seeking_VBG care_NN ._. We_PRP know_VBP that_IN a_DT smaller_JJR
        proportion_NN of_IN HMO_NNP enrollees_NNS were_VBD over_IN the_DT age_NN of_IN 85_CD years_NNS ,_,
        compared_VBN to_TO the_DT matched_VBN fee-for-service_JJ sample_NN ._.
        Differential_NNP enrollment_NN could_MD influence_VB our_PRP$ results_NNS if_IN
        patients_NNS with_IN higher_JJR degrees_NNS of_IN co-morbid_JJ conditions_NNS
        preferentially_RB enrolled_VBD in_IN the_DT fee-for_JJ service_NN system_NN and_CC
        did_VBD not_RB participate_VB in_IN cancer_NN screening_NN or_CC secondary_JJ
        diabetic_JJ prevention_NN because_IN of_IN their_PRP$ other_JJ illnesses_NNS ._. [_NN 52_CD
        ]_NN In_IN addition_NN ,_, the_DT annual_JJ visit_NN rate_NN could_MD potentially_RB be_VB
        overestimated_JJ in_IN the_DT HMO_NNP population_NN if_IN an_DT influx_NN of_IN new_JJ
        patients_NNS and_CC a_DT "_'' new_JJ enrollee_NN "_'' effect_NN were_VBD to_TO cause_VB more_JJR
        patients_NNS to_TO come_VB in_IN for_IN visits_NNS than_IN otherwise_RB would_MD ._.
        Another_DT potentially_RB important_JJ limitation_NN is_VBZ that_IN different_JJ
        data_NNS systems_NNS created_VBN for_IN different_JJ purposes_NNS ,_, such_JJ as_IN claims_NNS
        and_CC clinical_JJ databases_NNS ,_, may_MD not_RB provide_VB comparable_JJ results_NNS ,_,
        even_RB for_IN strictly_RB defined_VBN indicators_NNS ._. [_NN 53_CD 54_CD ]_NN
        The_DT use_NN of_IN performance_NN indicators_NNS to_TO compare_VB care_NN
        provided_VBN in_IN different_JJ settings_NNS usually_RB requires_VBZ expensive_JJ
        data_NNS gathering_NN ._. Indicators_NNPS based_VBN on_IN automated_VBN data_NNS systems_NNS
        offer_VBP partial_JJ relief_NN to_TO this_DT problem_NN ._. Our_PRP$ findings_NNS related_VBN
        to_TO staff_VB model_NN and_CC group_NN model_NN HMO_NNP types_NNS should_MD be_VB
        replicated_VBN in_IN other_JJ settings_NNS ,_, and_CC extended_VBD to_TO other_JJ types_NNS
        of_IN managed_VBN care_NN ._. While_IN the_DT staff_NN model_NN HMO_NNP share_NN of_IN the_DT
        market_NN is_VBZ shrinking_VBG ,_, group_NN and_CC network_NN model_NN health_NN
        maintenance_NN organizations_NNS are_VBP experiencing_VBG increased_VBN
        enrollment_NN ._. Our_PRP$ finding_NN of_IN concordance_NN on_IN many_JJ indicators_NNS
        between_IN the_DT Group_NNP and_CC Staff_NNP Model_NNP divisions_NNS suggests_VBZ that_IN a_DT
        less_RBR tightly_RB organized_VBN provider_NN system_NN may_MD perform_VB as_RB well_RB
        as_IN a_DT staff_NN model_NN HMO_NNP ._. Neither_DT of_IN the_DT HMO_NNP divisions_NNS studied_VBN
        resembles_VBZ an_DT independent_JJ practice_NN association_NN (_( IPA_NNP )_) model_NN ,_,
        so_RB our_PRP$ findings_NNS may_MD not_RB apply_VB to_TO that_DT form_NN of_IN provider_NN
        organization_NN ._. In_IN addition_NN we_PRP studied_VBD only_RB one_CD managed_VBN care_NN
        organization_NN ,_, one_CD that_WDT is_VBZ well_RB established_VBN ,_, and_CC exists_VBZ in_IN a_DT
        region_NN of_IN the_DT country_NN with_IN high_JJ level_NN access_NN to_TO specialty_NN
        services_NNS ._. The_DT generalizability_NN of_IN our_PRP$ findings_NNS to_TO other_JJ
        managed_VBN care_NN populations_NNS is_VBZ unknown_JJ ._. Furthermore_RB ,_, the_DT
        single_JJ HMO_NNP studied_VBD is_VBZ a_DT not-for_JJ profit_NN organization_NN ,_, and_CC
        our_PRP$ findings_NNS might_MD not_RB be_VB applicable_JJ to_TO for-profit_JJ
        entities_NNS ._. [_NN 55_CD ]_NN
      
      
        Conclusions_NNP
        In_IN conclusion_NN ,_, we_PRP believe_VBP that_IN the_DT indicators_NNS we_PRP have_VBP
        tested_VBN are_VBP feasible_JJ to_TO implement_VB in_IN other_JJ managed_VBN care_NN
        systems_NNS ,_, and_CC could_MD be_VB translated_VBN into_IN other_JJ electronic_JJ
        medical_JJ record_NN systems_NNS ._. Indicators_NNPS such_JJ as_IN these_DT might_MD be_VB
        useful_JJ for_IN consumers_NNS in_IN comparing_VBG health_NN plans_NNS to_TO one_CD
        another_DT ,_, such_JJ as_IN those_DT participating_VBG in_IN Medicare_NNP +_NN Choice_NN ._. We_PRP
        found_VBD no_DT evidence_NN of_IN any_DT decrement_NN in_IN access_NN to_TO health_NN care_NN
        for_IN the_DT elderly_JJ Medicare_NNP population_NN enrolled_VBD in_IN one_CD managed_VBN
        care_NN plan_NN in_IN this_DT geographic_JJ region_NN ._. The_DT low-_JJ or_CC no_DT cost_NN
        "_'' supplemental_JJ "_'' insurance_NN provided_VBN by_IN many_JJ HMOs_NNP may_MD in_IN fact_NN
        lower_JJR financial_JJ barriers_NNS to_TO care_VB for_IN low-income_JJ seniors_NNS ._.
        Our_PRP$ study_NN describes_VBZ only_RB two_CD models_NNS of_IN managed_VBN care_NN ,_, and_CC
        this_DT is_VBZ a_DT crude_NN classification_NN by_IN current_JJ standards_NNS ._. Yet_RB to_TO
        be_VB studied_VBN are_VBP the_DT effects_NNS of_IN financial_JJ incentives_NNS on_IN
        increasingly_RB smaller_JJR units_NNS of_IN leverage_NN ,_, e_SYM ._. g_SYM ._. small_JJ IPA_NNP
        model_NN groups_NNS ,_, and_CC the_DT effectiveness_NN of_IN managed_VBN care_NN plans_NNS
        that_WDT use_NN sophisticated_JJ information_NN systems_NNS to_TO track_VB and_CC
        improve_VB care_NN ,_, as_IN compared_VBN to_TO those_DT that_DT use_NN principally_RB
        financial_JJ incentives_NNS ._. [_NN 56_CD 57_CD ]_NN The_DT latter_NN is_VBZ crucial_JJ to_TO
        understanding_NN how_WRB best_JJS to_TO create_VB a_DT partnership_NN between_IN
        providers_NNS and_CC health_NN plans_NNS that_IN facilitates_NNS the_DT provision_NN
        of_IN excellent_JJ care_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD
      
    
  
